Intimate partner violence against HIV-positive Cameroonian women: Prevalence, associated factors and relationship with antiretroviral therapy discontinuity-results from the ANRS-12288 EVOLCam survey.
Marion FiorentinoLuis Sagaon-TeyssierKhadim NdiayeMarie Suzan-MontiMarie-Thérèse MengueLaurent VidalChristopher KuabanLaura MarchChristian LaurentBruno SpireSylvie Boyernull nullPublished in: Women's health (London, England) (2020)
Intimate partner violence is a potential barrier to antiviral therapy continuity and aggravates vulnerability of Cameroonian HIV-positive women. The prevention and detection of intimate partner violence by HIV services might help to reach the last "90" of the 90-90-90 targets.
Keyphrases
- intimate partner violence
- hiv positive
- antiretroviral therapy
- hiv infected
- men who have sex with men
- human immunodeficiency virus
- hiv infected patients
- south africa
- hiv aids
- polycystic ovary syndrome
- hiv testing
- pregnancy outcomes
- primary care
- healthcare
- cervical cancer screening
- mental health
- risk factors
- climate change
- stem cells
- insulin resistance
- pregnant women
- type diabetes
- loop mediated isothermal amplification
- mesenchymal stem cells
- hepatitis c virus
- skeletal muscle
- human health